Loading video...

Video Failed to Load

There was a problem loading this video. This could be due to a temporary network issue or the video might be unavailable.

So gratifying to see long-term memory in an aggressive tumor such as triple negative breast cancer. We see this result of long duration in pancreatic, bladder & lung cancer, confirming that maintaining ALC as an adjunct to modified current therapy results in long-term remission

Dr. Pat Soon-Shiong

155,336 subscribers

51,864 views • 8 months ago •via X (Twitter)

Health & Wellness Science & Technology

Anya Rossi• Live Now

Private livecam show

0 Comments

No comments available

Comments from the original post will appear here

Related Videos

STUDY: High-dose IV vitamin C linked to LONG-TERM REMISSION in three advanced cancer patients who declined chemotherapy. Metastatic kidney cancer: lung tumors DISAPPEARED; remission lasted more than 4 YEARS. Muscle-invasive bladder cancer: no recurrence or spread 9 YEARS later. Stage III aggressive lymphoma: no signs of cancer 10 YEARS later. NIH pathologists independently confirmed all 3 diagnoses.

STUDY: High-dose IV vitamin C linked to LONG-TERM REMISSION in three advanced cancer patients who declined chemotherapy. Metastatic kidney cancer: lung tumors DISAPPEARED; remission lasted more than 4 YEARS. Muscle-invasive bladder cancer: no recurrence or spread 9 YEARS later. Stage III aggressive lymphoma: no signs of cancer 10 YEARS later. NIH pathologists independently confirmed all 3 diagnoses.

Nicolas Hulscher, MPH

60,258 views • 1 month ago

Exciting results in lung cancer today. It is my belief that treating lymphopenia in patients with low NK and T cell count, is as essential as treating anemia (low red blood cells count) or neutropenia (low neutrophil count) which occurs as a consequence of chemotherapy, independent of tumor types. This will herald in the paradigm change of treating the immune system itself and allow the immune system to cure the cancer, regardless of its anatomical location. The long-term survival in patients with bladder cancer and now in lung cancer provide evidence of the potential validity of this hypothesis, with ANKTVIA as the foundation of the Bioshield platform.

Exciting results in lung cancer today. It is my belief that treating lymphopenia in patients with low NK and T cell count, is as essential as treating anemia (low red blood cells count) or neutropenia (low neutrophil count) which occurs as a consequence of chemotherapy, independent of tumor types. This will herald in the paradigm change of treating the immune system itself and allow the immune system to cure the cancer, regardless of its anatomical location. The long-term survival in patients with bladder cancer and now in lung cancer provide evidence of the potential validity of this hypothesis, with ANKTVIA as the foundation of the Bioshield platform.

Dr. Pat Soon-Shiong

43,531 views • 1 year ago

Today, we join with other cancer charities in calling on all political parties to commit to publishing a long-term cancer strategy for England to improve cancer outcomes. People affected by cancer need a plan #OneCancerVoice

Today, we join with other cancer charities in calling on all political parties to commit to publishing a long-term cancer strategy for England to improve cancer outcomes. People affected by cancer need a plan #OneCancerVoice

Cancer Research UK

26,277 views • 2 years ago

Launched this 20 yrs ago on #albumin and #Abraxane to educate oncologists about feeding the tumor in breast, lung & pancreatic #cancer. Frustrating it takes 20 yrs to recognize the impact of the biology of our body. Feed the tumor, don't starve it. Save your #immunesystems.

Launched this 20 yrs ago on #albumin and #Abraxane to educate oncologists about feeding the tumor in breast, lung & pancreatic #cancer. Frustrating it takes 20 yrs to recognize the impact of the biology of our body. Feed the tumor, don't starve it. Save your #immunesystems.

Dr. Pat Soon-Shiong

30,642 views • 1 year ago

We discovered that mRNA technology induces long-term genetic damage and biochemical HAVOC — turning THOUSANDS of genes on/off in ways that fuel cancer, clotting, inflammation, mitochondrial failure & immune dysfunction. Accountability for this global crime is long overdue.

We discovered that mRNA technology induces long-term genetic damage and biochemical HAVOC — turning THOUSANDS of genes on/off in ways that fuel cancer, clotting, inflammation, mitochondrial failure & immune dysfunction. Accountability for this global crime is long overdue.

Nicolas Hulscher, MPH

96,978 views • 8 months ago

We discovered that mRNA technology induces long-term genetic damage and biochemical HAVOC — turning THOUSANDS of genes off/on in ways that fuel cancer, clotting, inflammation, mitochondrial failure & immune collapse. Accountability for this global crime is LONG overdue.

We discovered that mRNA technology induces long-term genetic damage and biochemical HAVOC — turning THOUSANDS of genes off/on in ways that fuel cancer, clotting, inflammation, mitochondrial failure & immune collapse. Accountability for this global crime is LONG overdue.

Nicolas Hulscher, MPH

40,444 views • 6 months ago

🚨 PIERS MORGAN: "I was with one of the top cancer experts in Britain for lunch a couple of days ago, who was utterly scathing about the long-term impact of the mRNA vaccines ... and says that they're reaping a whirlwind in the world of cancer as a result of the vaccines."

🚨 PIERS MORGAN: "I was with one of the top cancer experts in Britain for lunch a couple of days ago, who was utterly scathing about the long-term impact of the mRNA vaccines ... and says that they're reaping a whirlwind in the world of cancer as a result of the vaccines."

Chief Nerd

3,705,894 views • 1 year ago

The recent breakthrough in pancreatic cancer therapy isn't a cure. But it *may be* a pathway to one. Pancreatic cancer has miserable survival rates. Most cases are driven by RAS, a protein long considered basically undruggable. Revolution Medicines found a way to target RAS with daraxonrasib, which nearly doubled median overall survival versus chemo, and was easier to tolerate. Crucially, being able to target RAS gives pancreatic cancer therapy a new foundation. Other drugs can be layered on top of daraxonrasib to even better results than the drug alone. Samuel Hume explains:

The recent breakthrough in pancreatic cancer therapy isn't a cure. But it may be a pathway to one. Pancreatic cancer has miserable survival rates. Most cases are driven by RAS, a protein long considered basically undruggable. Revolution Medicines found a way to target RAS with daraxonrasib, which nearly doubled median overall survival versus chemo, and was easier to tolerate. Crucially, being able to target RAS gives pancreatic cancer therapy a new foundation. Other drugs can be layered on top of daraxonrasib to even better results than the drug alone. Samuel Hume explains:

TBPN

62,355 views • 2 months ago

$🔬An international research team catalogued 25 tumor types from thousands of patient donors as part of a long-term NIH-funded cancer study. This is a major win for cancer research since previous collections only captured a fraction of cancer’s biological diversity. I look forward to seeing how these models accelerate discoveries and bring us closer to more precise, effective treatments for patients everywhere. Read the full story. ➡️$

🔬An international research team catalogued 25 tumor types from thousands of patient donors as part of a long-term NIH-funded cancer study. This is a major win for cancer research since previous collections only captured a fraction of cancer’s biological diversity. I look forward to seeing how these models accelerate discoveries and bring us closer to more precise, effective treatments for patients everywhere. Read the full story. ➡️

Jay Bhattacharya, MD, PhD

17,474 views • 28 days ago

I think it’s time for Congress to reassert itself. We owe that to those that we represent, as well as to this institution, for the long-term good of the nation.

I think it’s time for Congress to reassert itself. We owe that to those that we represent, as well as to this institution, for the long-term good of the nation.

Sen. Lisa Murkowski

93,466 views • 1 year ago

🇺🇸🇺🇦 Elections in Ukraine will take place when all Ukrainians can vote, all of them. - Blinken So as long as Russia holds territories, there will not be an election, even if there is a long term ceasefire or peace.

🇺🇸🇺🇦 Elections in Ukraine will take place when all Ukrainians can vote, all of them. - Blinken So as long as Russia holds territories, there will not be an election, even if there is a long term ceasefire or peace.

Lord Bebo

2,563,829 views • 2 years ago

The truth about breast-feeding and breast cancer Is it true that 1 in 20 breast cancers could be prevented by breast feeding? This was a statement lifted from the Lancet Breast Cancer Commission Report published yesterday - but it’s a global estimate that assumes EVERY woman in EVERY country has an average of 6 children and breastfeeds them for 1-2 years. The facts - breastfeeding one child for 12 months reduces your lifetime risk of breast cancer by 4% That’s a drop from 17% to 16.4% - so the actual impact is small. The Report wants to increase breast-feeding education and support globally as en masse this will reduce the numbers of breast cancer - but you don’t need to feel guilty if you didn’t breastfeed for that long or didn’t have children If you want to find out your own individual risk of breast cancer, check out the iPrevent tool - Thanks to Wanda (Wanyuan) Cui The Lancet Breast Cancer Now

The truth about breast-feeding and breast cancer Is it true that 1 in 20 breast cancers could be prevented by breast feeding? This was a statement lifted from the Lancet Breast Cancer Commission Report published yesterday - but it’s a global estimate that assumes EVERY woman in EVERY country has an average of 6 children and breastfeeds them for 1-2 years. The facts - breastfeeding one child for 12 months reduces your lifetime risk of breast cancer by 4% That’s a drop from 17% to 16.4% - so the actual impact is small. The Report wants to increase breast-feeding education and support globally as en masse this will reduce the numbers of breast cancer - but you don’t need to feel guilty if you didn’t breastfeed for that long or didn’t have children If you want to find out your own individual risk of breast cancer, check out the iPrevent tool - Thanks to Wanda (Wanyuan) Cui The Lancet Breast Cancer Now

Dr Liz O'Riordan

45,182 views • 2 years ago

The derailment of a train carrying toxic chemicals linked to cancer has raised concerns in the US of long-term health risks for the residents of East Palestine, Ohio ⤵️

The derailment of a train carrying toxic chemicals linked to cancer has raised concerns in the US of long-term health risks for the residents of East Palestine, Ohio ⤵️

Al Jazeera English

282,456 views • 3 years ago

🚨IVERMECTIN: FULL DOSAGE SCHEDULE FOR CANCER & PREVENTION Based on Dr. William Makis MD's commonly shared dosing framework Thousands of people reference this ivermectin dosing chart. Below is a simplified breakdown organized by body weight (mg/kg per day). 📌LOW DOSE ≤ 0.5 mg/kg/day Best For: • Cancers in remission • Strong family history or genetic predisposition • Preventive (prophylactic) use Reported Side Effects: • No long-term side effects reported Example: Dr. Tess Lawrie reported a Stage 3 ovarian cancer patient who received chemotherapy plus 12 mg ivermectin daily. After 2 months, the tumor marker CA125 fell from 288 to 22, and the tumor was reported to have disappeared. 📌MEDIUM DOSE 1.0 mg/kg/day Best For: • Starting dose for many cancers including: • Lung cancer • Pancreatic cancer • Renal cell carcinoma • Gastric cancer Reported Side Effects: • No long-term side effects reported Example: Dr. Shankara Chetty reported a 70-year-old prostate cancer patient with a PSA of 89 taking 45 mg daily (along with lactoferrin). After 2 months, PSA reportedly decreased to 10.9. 📌HIGH DOSE 2.0 mg/kg/day Best For: • Aggressive cancers • Leukemia • Pancreatic cancer • Brain cancers Reported Side Effects: • No long-term side effects reported Example: Dr. Allan Landrito reported a Stage 4 gallbladder cancer patient taking 2 mg/kg daily for 14 months, with the cancer reportedly disappearing. 📌VERY HIGH DOSE ≥ 2.5 mg/kg/day Best For: • Extensive metastatic disease • Extremely poor prognosis • Certain aggressive brain cancers Possible Side Effects: • Temporary visual disturbances • Usually, short lived and resolve within days Example: Dr. Shankara Chetty reported using 2.5 mg/kg/day in a patient with no side effects reported. #Ivermectin #MakisMD #Genixmeds

🚨IVERMECTIN: FULL DOSAGE SCHEDULE FOR CANCER & PREVENTION Based on Dr. William Makis MD's commonly shared dosing framework Thousands of people reference this ivermectin dosing chart. Below is a simplified breakdown organized by body weight (mg/kg per day). 📌LOW DOSE ≤ 0.5 mg/kg/day Best For: • Cancers in remission • Strong family history or genetic predisposition • Preventive (prophylactic) use Reported Side Effects: • No long-term side effects reported Example: Dr. Tess Lawrie reported a Stage 3 ovarian cancer patient who received chemotherapy plus 12 mg ivermectin daily. After 2 months, the tumor marker CA125 fell from 288 to 22, and the tumor was reported to have disappeared. 📌MEDIUM DOSE 1.0 mg/kg/day Best For: • Starting dose for many cancers including: • Lung cancer • Pancreatic cancer • Renal cell carcinoma • Gastric cancer Reported Side Effects: • No long-term side effects reported Example: Dr. Shankara Chetty reported a 70-year-old prostate cancer patient with a PSA of 89 taking 45 mg daily (along with lactoferrin). After 2 months, PSA reportedly decreased to 10.9. 📌HIGH DOSE 2.0 mg/kg/day Best For: • Aggressive cancers • Leukemia • Pancreatic cancer • Brain cancers Reported Side Effects: • No long-term side effects reported Example: Dr. Allan Landrito reported a Stage 4 gallbladder cancer patient taking 2 mg/kg daily for 14 months, with the cancer reportedly disappearing. 📌VERY HIGH DOSE ≥ 2.5 mg/kg/day Best For: • Extensive metastatic disease • Extremely poor prognosis • Certain aggressive brain cancers Possible Side Effects: • Temporary visual disturbances • Usually, short lived and resolve within days Example: Dr. Shankara Chetty reported using 2.5 mg/kg/day in a patient with no side effects reported. #Ivermectin #MakisMD #Genixmeds

GENIX MEDS

31,415 views • 3 months ago

A New Dawn in the Cancer War: Pioneering "BioShield" Technology Achieves Long-Term Remission Where Others Failed A stunning revelation from Dr. Patrick Soon-Shiong on the dawn of a new medical era. He details a breakthrough he calls "BioShield," a technology designed to prevent cancer by fundamentally educating the body's own immune system. Forget conventional vaccines. This isn't about antibodies. This is about creating a living, intelligent defense system within you. Here’s the concept: "BioShield" educates your T-cells to become elite "memory" cells. They then hide in your bone marrow, lying in wait. When a cancerous cell appears, they emerge to seek and destroy it—stopping cancer before it can ever gain a foothold. This isn't science fiction. It's peer-reviewed, published science with the National Cancer Institute (NCI). And the results are nothing short of remarkable: ➡️ Bladder Cancer: Patients who failed all other treatments and faced radical bladder removal have achieved complete remission for nine years after a simple injection. No surgery. Just a functional cure. ➡️ Pancreatic Cancer: A disease with a grim prognosis, now seeing patients disease-free for five years. The late Senator Harry Reid, after being told by others not to pursue it, saw his tumor markers normalize and lived two active, cancer-free years. ➡️ Merkel Cell Carcinoma & Head/Neck Cancer: Stories of complete responses in patients given weeks to live, with one living nine years and another saved from hospice when his ulcerating tumor melted away. Dr. Soon-Shiong is reframing the conversation. This isn't a "vaccine" in the traditional sense. It's Project BioShield—a proactive, cellular guardian for the body. The takeaway? We are transitioning from toxic, reactive cancer therapies to intelligent, preemptive protection. The age of the immune system as our most powerful shield against cancer has arrived. What are your thoughts on this "BioShield" approach to cancer?

A New Dawn in the Cancer War: Pioneering "BioShield" Technology Achieves Long-Term Remission Where Others Failed A stunning revelation from Dr. Patrick Soon-Shiong on the dawn of a new medical era. He details a breakthrough he calls "BioShield," a technology designed to prevent cancer by fundamentally educating the body's own immune system. Forget conventional vaccines. This isn't about antibodies. This is about creating a living, intelligent defense system within you. Here’s the concept: "BioShield" educates your T-cells to become elite "memory" cells. They then hide in your bone marrow, lying in wait. When a cancerous cell appears, they emerge to seek and destroy it—stopping cancer before it can ever gain a foothold. This isn't science fiction. It's peer-reviewed, published science with the National Cancer Institute (NCI). And the results are nothing short of remarkable: ➡️ Bladder Cancer: Patients who failed all other treatments and faced radical bladder removal have achieved complete remission for nine years after a simple injection. No surgery. Just a functional cure. ➡️ Pancreatic Cancer: A disease with a grim prognosis, now seeing patients disease-free for five years. The late Senator Harry Reid, after being told by others not to pursue it, saw his tumor markers normalize and lived two active, cancer-free years. ➡️ Merkel Cell Carcinoma & Head/Neck Cancer: Stories of complete responses in patients given weeks to live, with one living nine years and another saved from hospice when his ulcerating tumor melted away. Dr. Soon-Shiong is reframing the conversation. This isn't a "vaccine" in the traditional sense. It's Project BioShield—a proactive, cellular guardian for the body. The takeaway? We are transitioning from toxic, reactive cancer therapies to intelligent, preemptive protection. The age of the immune system as our most powerful shield against cancer has arrived. What are your thoughts on this "BioShield" approach to cancer?

Camus

31,209 views • 9 months ago

Dr. Patrick Soon-Shiong presents a fundamental paradigm shift in the war on cancer: we must stop destroying the immune system to save the body, and start supercharging it to achieve a permanent cure. The critical flaw of conventional chemotherapy and radiation is their inadvertent destruction of the very immune cells—the lymphocytes—designed to protect us. This often wins a battle but loses the war, leading to metastasis. The solution lies within us. Dr. Soon-Shiong’s work harnesses "God's design": the power of Natural Killer (NK) cells and T-cells. The breakthrough is two-fold: 1. The Activation Key: For the first time, we can effectively activate these cells using a sustained-release form of IL-15, a natural protein. A single injection can create a tenfold increase in the body's innate cancer-killing army. 2. The Army Expansion: We can now draw a patient's blood, grow billions of targeted NK cells in a lab, and reinfuse them, creating a supercharged, augmented immune response. This is not an incremental improvement. It is a move away from the failed strategy of attacking cancer from the inside-out—blocking internal pathways that cancer easily bypasses—to shattering it from the outside-in. The result is data that speaks to a potential cure: patients with metastatic pancreatic cancer alive and disease-free after five years; bladder cancer patients thriving with their organs intact a decade after treatment; long-term remission in aggressive Merkel cell carcinoma. This approach teaches the immune system "T-cell memory," creating a permanent, living surveillance system that stands guard against recurrence. This is the path to long-term survival with quality of life.

Dr. Patrick Soon-Shiong presents a fundamental paradigm shift in the war on cancer: we must stop destroying the immune system to save the body, and start supercharging it to achieve a permanent cure. The critical flaw of conventional chemotherapy and radiation is their inadvertent destruction of the very immune cells—the lymphocytes—designed to protect us. This often wins a battle but loses the war, leading to metastasis. The solution lies within us. Dr. Soon-Shiong’s work harnesses "God's design": the power of Natural Killer (NK) cells and T-cells. The breakthrough is two-fold: 1. The Activation Key: For the first time, we can effectively activate these cells using a sustained-release form of IL-15, a natural protein. A single injection can create a tenfold increase in the body's innate cancer-killing army. 2. The Army Expansion: We can now draw a patient's blood, grow billions of targeted NK cells in a lab, and reinfuse them, creating a supercharged, augmented immune response. This is not an incremental improvement. It is a move away from the failed strategy of attacking cancer from the inside-out—blocking internal pathways that cancer easily bypasses—to shattering it from the outside-in. The result is data that speaks to a potential cure: patients with metastatic pancreatic cancer alive and disease-free after five years; bladder cancer patients thriving with their organs intact a decade after treatment; long-term remission in aggressive Merkel cell carcinoma. This approach teaches the immune system "T-cell memory," creating a permanent, living surveillance system that stands guard against recurrence. This is the path to long-term survival with quality of life.

Camus

103,022 views • 11 months ago